English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 26 September 2012, 07:45 HKT/SGT
Share:
    

Source: INC Research, LLC
INC Research, LLC Third Quarter 2012 Results of Operations Release Date and Conference Call

Raleigh, NC, Sept 26, 2012 - (ACN Newswire) - INC Research, LLC (the "Company"), a therapeutically focused clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, will conduct a conference call to discuss its third quarter 2012 financial results at 11:00 a.m. ET on Tuesday, November 13, 2012. The third quarter financial results will be available on the Company's secure website no later than November 12, 2012.

To access the financial results and dial-in information for the conference call, a party must pre-register and certify that it is eligible to do so. Access to the financial results and conference call will be available only to (1) holders of the Company's 11.5% Senior Notes due 2019, (2) hi-yield securities analysts and broker-dealers and (3) prospective investors that certify that they are qualified institutional buyers as defined in Rule 144A under the Securities Act of 1933, as amended. To receive information on how to pre-register and certify eligibility, parties must send an email to wlumpkin@incresearch.com requesting access to the financial results and conference call information no later than August 10, 2012.

About INC Research, LLC

INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areasand innovative pediatric and women's health trials. The Company's Trusted Process(R) methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.

Contact:
INC Research, LLC
Willis Lumpkin, Treasurer,
+1-919-341-3230


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: INC RESEARCH, LLC via Thomson Reuters ONE

Topic: Press release summary
Source: INC Research, LLC


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

INC Research, LLC Related News
Nov 7, 2014 08:50 HKT/SGT
INC Research Announces Pricing of Initial Public Offering
Oct 7, 2014 07:10 HKT/SGT
INC Research Files Registration Statement for Initial Public Offering
Oct 3, 2014 10:30 HKT/SGT
INC Research Demonstrates Continued Dedication to Site Relationships at 2014 SCRS Site Solutions Summit
Oct 2, 2014 07:20 HKT/SGT
INC Research Further Reinforces Commitment to Clinical Research Sites and Patients through Creation of New Leadership Role
Aug 6, 2014 03:30 HKT/SGT
INC Research's Tara Fitzgerald and Judy Swilley Named to Annual PharmaVOICE 100
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575